nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Airway hyperresponsiveness in FVB/N delta F508 cystic fibrosis transmembrane conductance regulator mice
|
Bazett, Mark |
|
2014 |
13 |
4 |
p. 378-383 6 p. |
artikel |
2 |
CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy
|
Beekman, Jeffrey M. |
|
2014 |
13 |
4 |
p. 363-372 10 p. |
artikel |
3 |
Commentary for JCF review “Drug induced complications; can we do more?” J Cyst Fibros 2013 Dec;12(6):547–58
|
Taylor, C.J. |
|
2014 |
13 |
4 |
p. 485- 1 p. |
artikel |
4 |
Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis
|
Downes, Kevin J. |
|
2014 |
13 |
4 |
p. 435-441 7 p. |
artikel |
5 |
Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis
|
Kondori, Nahid |
|
2014 |
13 |
4 |
p. 391-399 9 p. |
artikel |
6 |
Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients
|
Leclercq, A. |
|
2014 |
13 |
4 |
p. 478-484 7 p. |
artikel |
7 |
Editorial Board
|
|
|
2014 |
13 |
4 |
p. ii- 1 p. |
artikel |
8 |
Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis
|
Di Cicco, Maurizio |
|
2014 |
13 |
4 |
p. 455-460 6 p. |
artikel |
9 |
ESCF Care Guidelines beyond Europe
|
Gutierrez M.D., Hector H. |
|
2014 |
13 |
4 |
p. 359-360 2 p. |
artikel |
10 |
European cystic fibrosis society standards of care: A road map to improve CF outcome
|
Kerem, Eitan |
|
2014 |
13 |
4 |
p. 357-358 2 p. |
artikel |
11 |
Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: An analysis of the UNOS registry
|
Hayes Jr., Don |
|
2014 |
13 |
4 |
p. 416-423 8 p. |
artikel |
12 |
Nebulized voriconazole in infections with Scedosporium apiospermum — Case report and review of the literature
|
Holle, J. |
|
2014 |
13 |
4 |
p. 400-402 3 p. |
artikel |
13 |
Neonatal screening for cystic fibrosis: Comparing the performances of IRT/DNA and IRT/PAP
|
Sarles, Jacques |
|
2014 |
13 |
4 |
p. 384-390 7 p. |
artikel |
14 |
Neonates with cystic fibrosis have a reduced nasal liquid pH; A small pilot study
|
Abou Alaiwa, Mahmoud H. |
|
2014 |
13 |
4 |
p. 373-377 5 p. |
artikel |
15 |
Paranasal sinus pathogens in children with cystic fibrosis: Do they relate to lower respiratory tract pathogens and is eradication successful?
|
Wilson, P. |
|
2014 |
13 |
4 |
p. 449-454 6 p. |
artikel |
16 |
Prescribing practices for intravenous aminoglycosides in UK Cystic Fibrosis clinics: A questionnaire survey
|
Smyth, Alan R. |
|
2014 |
13 |
4 |
p. 424-427 4 p. |
artikel |
17 |
Rate of improvement of CF life expectancy exceeds that of general population—Observational death registration study
|
Hurley, Matthew N. |
|
2014 |
13 |
4 |
p. 410-415 6 p. |
artikel |
18 |
Reply to Professor Taylor
|
Peckham, Daniel |
|
2014 |
13 |
4 |
p. 486-487 2 p. |
artikel |
19 |
Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis
|
Hennig, Stefanie |
|
2014 |
13 |
4 |
p. 428-434 7 p. |
artikel |
20 |
Simultaneous liver–pancreas transplantation for cystic fibrosis-related liver disease: A multicenter experience
|
Bandsma, R.H.J. |
|
2014 |
13 |
4 |
p. 471-477 7 p. |
artikel |
21 |
Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: A double-blind placebo-controlled cross-over trial
|
Mainz, Jochen G. |
|
2014 |
13 |
4 |
p. 461-470 10 p. |
artikel |
22 |
Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype?
|
Berkhout, M.C. |
|
2014 |
13 |
4 |
p. 442-448 7 p. |
artikel |
23 |
The challenge of improving outcomes for patients with CF sinonasal disease
|
VanDevanter, Donald R. |
|
2014 |
13 |
4 |
p. 361-362 2 p. |
artikel |
24 |
The relative frequency of CFTR mutation classes in European patients with cystic fibrosis
|
De Boeck, K. |
|
2014 |
13 |
4 |
p. 403-409 7 p. |
artikel |